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The new bone formation in human 
maxillary sinuses using two 
bone substitutes with different 
resorption types associated or not 
with autogenous bone graft: a 
comparative histomorphometric, 
immunohistochemical and randomized 
clinical study
Objective: The aim of this study is to evaluate the new bone and 
connective tissue formation and the biomaterial remaining after maxillary 
sinus bone augmentation using 5 different bone substitutes. The osteocalcin 
immunolabeling was performed to demonstrate their calcification and the 
possibility of receiving dental implants. Methodology: 40 patients underwent 
maxillary sinus bone augmentation and were divided in 5 groups: Group 1 
with 8 maxillary sinuses were grafted with autogenous bone graft (AB); Group 
2 with 8 maxillary sinuses grafted with bioactive glass (BG); Group 3 with 
8 maxillary sinuses grafted with bioactive glass added to autogenous bone 
graft (BG + AB) 1:1; Group 4 with 8 maxillary sinuses grafted with Bio-Oss 
(BO) and Group 5 with 8 maxillary sinuses grafted with Bio-Oss added to 
autogenous bone graft (BO + AB) 1:1. Results: In group AB, 37.8% of bone 
was formed in the pristine bone region, 38.1% in the intermediate and 44.5% 
in the apical region. In group BG, 43.6% was formed in the pristine bone, 
37% in the intermediate and 49.3% in the apical region. In group BG + AB 
1:1, 39.0% was formed in the pristine bone region, 34.8% in the intermediate 
and 36.8% in apical region. In group BO, 33.4% was formed in the pristine 
bone, 32.5% in the intermediate and 34.3% in the apical region. In group 
BO + AB 1:1, 32.8% was formed in the pristine bone, 36.1% in intermediate 
and 27.8% in the apical regions. The immunolabeling for osteocalcin showed 
an intensive staining for all groups, which could demonstrate the calcification 
of the bone formed. Conclusion: This study showed that the groups evaluated 
formed a suitable lamellar bone in the maxillary sinus reconstruction after 
six months of bone healing, thus being indicated to receive dental implants.
Keywords: Biomaterials. Bone substitutes. Sinus floor augmentation. 
Tissue physiology. Bone regeneration. Xenograft. Bioactive glass.
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Introduction
Physiological phenomena such as bone resorption 
and maxillary sinus pneumatization occur when 
the posterior maxillary teeth are lost.1 Since oral 
rehabilitation using dental implants is impossible at 
this point, bone reconstruction is the procedure of 
choice.
Different surgical techniques that depend on the 
residual bone on the maxillary sinus floor have been 
developed.2 The posterior maxillary reconstruction is 
then considered a predictable and reliable procedure. 
Since its creation by Boyne and James, different bone 
substitutes have been used as autogenous bone grafts, 
xenografts and allografts, among others.3-5
However, an ideal bone substitute is yet to be 
described in the literature.6 Among the numerous 
biomaterials created and researched over the years, 
the autogenous bone graft (AB) is considered the 
“gold standard” due to its specific properties, namely 
osteoconduction, osteoinduction, and osteogenesis.
Bio-Oss (BO) (Geistlich Biomaterials, Wolhusen, 
LU, Switzerland) is the most used bone substitute, 
consisting of a deproteinized bovine bone with 
osteoconductive properties that has shown promising 
results due to its morphology similar to the human 
bone.7,8 Bioactive glass (BG) (Biogran; Biomet, 
Warsaw, IN, USA) is another biomaterial with 
promising results, consisting of an osteoconductive 
ceramic with peculiar properties of graft resorption 
due to the chemical dissolution.9,10
The aim of this study was to compare the new 
bone formation in human maxillary sinuses grafted 
with these two bone substitutes (Biogran & Bio-
Oss), which have different resorption pathways, 
using histomorphometric and immunohistochemical 
analysis, and to determine the effects of their addition 
to autogenous bone graft (1:1) after 6 months of 
bone healing.
Hypothesis 
H0 – There will be no difference in the new bone 




All procedures performed in studies involving 
human participants were in accordance with the 
ethical standards of the institutional and national 
research committee approved with the number 
47711015.4.0000.5420 by Plataforma Brasil/CONEP; 
with the 1964 Helsinki Declaration and its later 
amendments.
Quality assessment was conducted according to 
the CONSORT Statement’s RCT checklist11 (Figure 1).
Sample size
Based on previous studies, the number of maxillary 
sinuses to be grafted were determined by performing 
a power test on the website www.lee.dante.br 12. For 
this test, the difference of the mean was 15.1, with a 
standard deviation of 9.9. The test was conducted in 
a 1-tailed hypothesis with a 5% level of significance 
and a 80% power. The results indicated a minimum 
of 5 samples for each group.
Randomization
Drawing lots was performed to randomize and 
decide the sites to be grafted with each material by 
a clinical assistant.
Inclusion & exclusion criteria
All patients were subjected to facial cone beam 
computed tomography (CBCT) to evaluate the 
maxillary sinuses, as well as the proximity of 
mandibular canal and inferior dental roots where the 
autogenous bone graft were harvested. The inclusion 
criteria were: patients with maxillary sinuses with less 
than 5 mm of bone remaining; those who decided to 
be rehabilitated with dental implants; and those with 
bone in the mandibular symphysis or in the retromolar 
region. Exclusion criteria were: patients that reported 
uncontrolled systemic disease, untreated periodontal 
disease, or sinus pathologies; smokers; patients 
without enough bone at the mandibular regions to be 
harvested for the autogenous bone graft; patients who 
reported medication-related osteonecrosis, or patients 
treated for head and neck cancer.
Group determination
Based on the aforementioned parameters, 40 
patients were selected for unilateral maxillary sinus 
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bone augmentation and divided into 5 groups:
Group 1: eight maxillary sinuses grafted with AB 
as control group;
Group 2: eight maxillary sinuses grafted with BG;
Group 3: eight maxillary sinuses grafted with BG 
+ AB 1:1;
Group 4: eight maxillary sinuses grafted with BO,
Group 5: eight maxillary sinuses grafted with BO 
+ AB 1:1.
Surgical procedure
Surgical procedures were performed under local 
anesthesia using lidocaine 2% with 1:100 epinephrine 
(DFL; Taquara, RJ, Brazil). The autogenous bone graft 
was harvested from retromolar region by vestibular 
approach similar to that of mandibular sagittal 
osteotomy and osteotomized using 701 drill. The 
harvesting from symphysis were performed by an 
intraoral anterior vestibular approach, 5 mm below the 
gingival line extending from canine tooth. The bone 
was also osteotomized using a 701 drill and removed 
using a chisel.9,12,13 The bone blocks were grounded 
with a bone crusher (Neodent; Curitiba, PR, Brazil). 
The maxillary sinuses were treated according to 
Boyne and James3 (1980) using a posterior maxillary 
approach to expose the lateral wall of maxillary bone 
followed by a osteotomy using a nº 6 sphere drill to 
access the Schneiderian membrane and its elevation. 
The bone grafts were mixed using a syringe in cc to 
allow the 1:1 proportion. Post-operative pain was 
treated with 500 mg paracetamol (EMS; São Paulo, 
SP, Brazil), prescribed four times per day and 500 mg 
amoxicillin (EMS; São Paulo, SP, Brazil) was prescribed 
three times per day to reduce the chances of infection.
Histology & histomorphometric analysis
After 6 months of bone repair, bone biopsies were 
harvested using a 3.0 mm × 15 mm trephine bur (MK 
Life; Porto Alegre, RS, Brazil) at the time of dental 
implants placement and stored in a 10% formalin 
solution (pH 7) for 48 h. The samples were washed 
in running water for 24 hours, decalcified for 4 weeks 
in an EDTA solution changed weekly. Subsequently, 
they were embedded in paraffin; sectioned and 
stained with hematoxylin and eosin. Samples were 
identified and stored following the apical orientation 
in all sequence during laboratory procedures. The 
biopsies were evaluated according to Pereira, et al.12 
(2017) in three regions using a light microscopy with 
a digital camera attached to capture the images at 
×12.5 magnification:
- pristine bone (2 mm above the maxillary sinus 
floor), 
- intermediate, 
- apical (2 mm below the membrane) 
To exclude the influence of maxillary sinus floor and 
Figure 1- CONSORT diagram of the patient allocation by randomization
PEREIRA RS, BONARDI JP, OUVERNEY FR, CAMPOS AB, GRIZA GL, OKAMOTO R, HOCHULI-VIEIRA E
J Appl Oral Sci. 2021;29:e202005684/9
Schneiderian membrane during the evaluation, a 2 mm 
distance from upper and lower regions was respected. 
The height of pristine bone region was measured in 
the CBCT previously performed to exclude it during the 
microscope visualization. New bone formation, amount 
of connective tissue and the remaining biomaterial 
were analyzed by histometry using a grid of Merz14 
(1968).
Immunohistochemical evaluation
The immunohistochemical analysis was performed 
according to Pereira, et al.15 (2017). Primary polyclonal 
goat antibodies against human Osteocalcin (Santa 
Cruz Biotechnology; CA, USA; SC18319) were used 
in immunohistochemical assays to identify calcified 
tissue.16 A biotinylated donkey anti-goat secondary 
antibody (Jackson Immunoresearch Laboratories, 
West Grove, PA, USA) coupled to avidin (Vector 
Laboratories, Burlingame, CA, USA) was used for 
signal amplification. The binding reaction was detected 
with diaminobenzidine (Sigma-Aldrich, St Louis, MO, 
USA). Data analyses were performed using a single-
evaluator semi-quantitative approach, with score “0” 
indicating the absence of staining and scores “1,” “2,” 
or “3” indicating low, moderate, or intense staining, 
respectively.
Statistical analysis 
The Kolmogorov-Smirnov test was performed to 
indicate the parametric or non-parametric distribution 
of the samples. In case of normal distribution, a 
comparison among the groups was made using the 
ANOVA test followed by Tukey’s multiple comparison 
test. In case of non-parametric distribution, a Kruskal-
Wallis test was performed. A priori, p-value<0.05 was 
considered significant for all tests.
Results
Forty patients (22 men and 18 women) aged 
between 32 and 65 years old were subjected to 
unilateral maxillary sinus bone augmentation using the 
5 types of bone grafts purposed in our study.
Histology & histomorphometric outcomes
The group AB presented predominant lamellar 
bone formation in all three regions evaluated, with 
the presence of osteocytes in the bone matrix. The 
mean for the new bone formed was 37.8%±16.9 
in the pristine bone region; 38.1%±21.4 in the 
intermediate region and 44.5%±18.6 in the apical 
region. The connective tissue formed presented a 
mean of 57.6%±16.3 in pristine bone; 58.8%±20.9 
in intermediate and 54.0%±16.5 in apical region. The 
median for the remaining biomaterial was 1.5 in the 
pristine bone region, 0.5 in the intermediate region 
and 2.5 in the apical region.
The group BG showed new bone formation, which 
were in the process of lamellar organization in all 
three regions. However, in most cases, the presence 
of lamellar bone organization was observed. We also 
observed the presence of cellularized connective 
tissue with remaining bioactive glass particles and 
osteoblasts in the periphery of the bone matrix. The 
mean of new bone formed was 43.6%±4.7; 37%±10.9 
and 49.3%±13.2 in the pristine bone, intermediate 
and apical region, respectively. The connective tissue 
presented a 56.6%±6.5 mean for pristine bone; 
63.4%±11.0 for intermediate and 49.3%±13.2 for 
apical region. The median for the 3 regions evaluated 
for the present group was 0. 
In group BG + AB 1:1, a new bone formation 
with lamellar organization were observed, mostly 
showing more woven bone formation presented in 
the apical region. The connective tissue had cells and 
osteoblasts in the periphery of the bone matrix. The 
mean for new bone formed was 39.0%±15.8 in the 
pristine bone region; 34.8%±14.5 in the intermediate 
and 36.8%±14.5 in apical region. For the connective 
tissue, a 60.3%±11.9 mean was observed in the 
pristine bone; 62.1%±14.5 in the intermediate and 
58.5%±13.6 in the apical region. The median for the 
remaining biomaterial was 1.5 in the pristine bone 
region; 1 in the intermediate region and 2.5 in the 
apical region.
The group BO presented lamellar new bone 
formation in the three regions evaluated in a 
cellularized connective tissue stroma and much 
remaining biomaterial. The mean for the new bone 
formed was 33.4%±12.6 in the pristine bone; 
32.5%±10.8 in the intermediate and 34.3%±12.7 
in the apical region. The amount of connective tissue 
formed in the pristine bone region was 38.3%±9.5; 
in the intermediate region was 40.9%±7.1 and 
41.0%±7.2 in the apical region. The median for the 
remaining biomaterial in this group was 36.0 in pristine 
bone; 26.5 in intermediate and 25.5 in apical region.
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The group BO + AB 1:1 had lamellar bone 
formation with less remaining biomaterial due to 
autogenous bone graft particle resorption and less 
use of xenograft. The mean of the new bone formed 
in group 5 in the pristine bone, intermediate and 
apical regions was 32.8%±11.5; 36.1%±16.0 and 
27.8%±19.8 respectively. For connective tissue, the 
mean in the pristine bone region was 46.9%±14.5; 
in the intermediate region was 40.9%±21.2 and in 
the apical region was 43.4%±15.9. The remaining 
biomaterial median was 22.5 for pristine bone; 24.5 
for the intermediate and 36.0 for the apical region. 
Osteoclasts were absent around the bioactive glass or 
xenografts of specimens. (Figure 2 Histology sections) 
(Table 1).
The difference between new bone formation among 
groups and regions was not statistically significant 
(p<0.05). For connective tissue, the difference was 
statistically significant among groups (p=0.0001). 
Tukey’s post hoc test detected statistically significant 
differences between groups AB and BG + AB 1:1 
(p=0.001); groups AB and BO + AB 1:1 (p=0.012); 
groups BG and BO (p=0.001); groups BG and BO 
+ AB 1:1 (p=0.023); groups BG + AB 1:1 and BO 
(p=0.0001) as well as groups BG + AB 1:1 and BO + 
AB 1:1 (p=0.001). The comparison among groups for 
remaining biomaterial also had a statistically significant 
difference (X2=59.232; p=0.0001). The test showed 
difference between groups AB and BO (p=0.0001); 
groups AB and BO + AB 1:1 (p=0.0001); groups BG 
and BO (p=0.0001); groups BG and BO + AB 1:1 
(p=0.0001); groups BG + AB 1:1 and BO (p=0.0001) 
and groups BG + AB 1:1 and BO + AB 1:1 (p=0.001). 
Besides this, statistically significant differences were 
observed among regions for remaining biomaterial by 
the post hoc test (X2=61.156; p=0.0001): pristine bone 
region of groups AB and BO (p=0.048), pristine bone 
of group AB and apical region of group BO (p=0.025); 
pristine bone region of group AB and apical region of 
group BO + AB 1:1 (p=0.004). The differences were 
also observed among the intermediate region of group 
BG and the pristine bone (p=0.020), intermediate 
(→) Lamellar bone formation  
(■) Bioactive glass particle remaining
(ê) Xenograft particle remaining
() Yellow immunolabeling positive for Osteocalcin
Figure 2- Image showing the histological sections for histology evaluation and immunolabeling positive for Osteocalcin in the groups 
evaluated



















1 37.8±16.9 38.1±21.4 44.5±18.6 57.6±16.3 58.8±20.9 54.0±16.5 1.5 0.5 2.5
2 43.6±4.7 37.3±10.9 49.3±13.2 56.6±6.5 63.4±11.0 49.3±13.2 0 0 0
3 39.0±15.8 34.8±14.5 36.8±14.5 60.3±11.9 62.1±14.5 58.5±13.6 1.5 1 2.5
4 33.4±12.6 32.5±10.8 34.3±12.7 38.3±9.5 40.9±7.1 41.0±7.2 36.0 26.5 25.5
5 32.8±11.5 36.1±16.0 27.8±19.8 46.9±14.5 40.9±21.9 43.4±15.9 22.5 24.5 36.0
Table 1- Histometric outcomes for new bone formation, Connective tissue and Biomaterial remaining after 6 months of bone repair in the 
5 groups evaluated
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(p=0.022), and apical region (p=0.011) of group 
BO. The apical region of group BO + AB 1:1 showed 
difference among pristine bone region of group AB 
(p=0.004) and the intermediate region (p=0.002) and 
apical region (p=0.011) of group BG. (Figure 3 A, B)
Therefore, our results were in accordance with 
hypothesis H0.
Immunohistochemistry evaluation
Group AB presented high level “3” immunolabeling 
results for osteocalcin, which points to a mature bone 
that is able to receive dental implants for group BG; for 
group BG + AB 1:1; for group BO and group BO + AB 
1:1 (Figure 2 Osteocalcin immunolabeling sections).
Discussion
In our study, we evaluated the bone formation 
in human maxillary sinus bone augmentation using 
two different bone grafts. Previous literature reports 
that Biogran and Bio-Oss have different ways of graft 
resorption. Lindhe, et al.17 (2010) evaluated Bio-Oss 
Collagen in human sockets, concluding that Bio-Oss 
particles were not reabsorbed and bone formation 
was delayed after 6 months. Hallman, Lundgren 
and Sennerby18 (2001) and Lindgren, et al.19 (2012) 
analyzed bone specimens from human maxillary 
sinuses augmented with Bio-Oss and found 12.4% 
and 24.0% of particles after 3 years, respectively. 
Our study showed a 36.0% median  of Bio-Oss in the 
pristine bone region; 26.5% in the intermediate and 
25.5% in the apical region. The presence of osteoclasts 
around the graft remaining were not observed. Our 
data are in line with previous studies, which outline 
that Bio-Oss tends to be “resistant to resorption”.19
Biogran has a peculiar way of resorption: body 
fluids react with these bone substitute due to its 
unstable structure. A silica gel and calcium phosphate 
layer are formed around the particle surface, which 
allow a combined process of chemical dissolution and 
macrophage action.10 With simultaneous colonization 
of osteoblasts, the particle disintegrates. A rate 
of bioactive glass particles remaining from 0% to 
4.2% was reported after 6 months of bone healing 
in maxillary sinus bone augmentation, similar to our 
(ê)Occurred statistically significant difference (p<0.05).
(u)Occurred statistically significant difference (p<0.05).
()Occurred statistically significant difference (p<0.05).
(l)Occurred statistically significant difference (p<0.05).
(À)Occurred statistically significant difference (p<0.05).
(■)Occurred statistically significant difference (p<0.05).
Figure 3- A. Graphic showing the histomorphometric outcomes for new bone formation after 6 months of bone repair in the human 
maxillary sinus augmented with the 5 bone substitutes studied. B. Graphic showing the histomorphometric outcomes for connective tissue 
after 6 months of bone repair in the human maxillary sinus augmented with the 5 bone substitutes studied
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study, in which we report a 0% median in all regions 
evaluated.20 Thus, we demonstrated that another crack 
formed after each particle divided, and the occurrence 
of a new osteoblast activity.
Previous studies show different rates of new bone 
formation in maxillary sinus bone augmentation using 
both biomaterials. Rodriguez y Baena et al.21 (2017) 
reported a 27.5% bone formation using Bio-Oss and 
16.6% of residual graft. Lee, et al.22 (2017) found 
26.1% of new bone formed and 25.7% of residual 
Bio-Oss. Nizam, et al.23 (2018) demonstrated a 21.2% 
bone volume, similar to the outcomes reported in 
our study. Histometric studies using Biogran alone 
are scarce. Tadjoedin, et al.24 (2002) evaluated it; 
however, only 3 patients were operated upon and, 
therefore, their results cannot be considered reliable. 
Pereira, et al.20 (2017) researched the use of Biogran to 
reconstruct maxillary sinuses compared to autogenous 
bone graft. Their results showed a 42.0% mean of 
new bone formation in the pristine bone, 40.7% in the 
intermediate and 45.6% in the apical region, which is 
similar to the outcomes of our study.
Despite the autogenous bone graft being the most 
predictable for bone reconstructions, some authors 
showed that the requirement of another surgical site 
leads to post-operative morbidity.25-27 Recent studies 
reported post-surgical complaints immediately after 
the procedure, and that they tend to decrease in a 
long term.13 Besides this, osteoinductive properties 
and mesenchymal cells can be transferred with the 
autogenous bone graft and provide advantages when 
added to biomaterials to improve the bone quality.28-30
In our study, the composite bone graft studied 
did not result in a statistically significant difference in 
the rate of new bone formation. Group BG + AB 1:1 
showed a mean of 39.0%, 34.8%, and 36.8% in the 
pristine bone, intermediate region and apical region, 
respectively. Cordioli, et al.31 (2001) reported a 30.6% 
bone formation rate of Biogran and autogenous bone 
graft in a 4:1 ratio. Turunen, et al.32 (2004) grafted 
human maxillary sinuses with Biogran and autogenous 
bone graft from iliac crest in a 1:1 proportion with a 
34.0% result, similar to the study of Menezes, et al.9 
(2018).
When Bio-Oss plus autogenous bone graft is used 
to reconstruct maxillary sinuses, lower rates of new 
bone is formed. Yildirim, et al.28 (2001) showed that 
18.9% of bone is formed using this mixture, as well as 
Bonardi, et al.8 (2018). When the Bio-Oss associated 
to A-PRF and i-PRF is used to reconstruct mandible, 
similar histological findings were identified by Lorenz, 
et al.33 (2018), in which the new bone formed was 
in direct contact with the biomaterial remaining with 
lamellar formation. In our study, we also found low 
rates of new bone formation; however, the histological 
findings presented lamellar bone and a connective 
tissue well cellularized. Thus, the H0 hypothesis was 
accepted.
The osteocalcin outcomes demonstrate that all 
bone substitutes evaluated in this study were calcified 
and able to receive dental implants, similar to previous 
studies.8,15
The limitation of our study was the evaluation of 
dental implants in a long-term. According to literature, 
however, high rates of success are observed when Bio-
Oss is used to reconstruct the bone height in maxillary 
sinuses.30 Despite the outcomes showed in this study, 
further studies are required to evaluate other periods 
and demonstrate if the biomaterial particle rates 
influence bone healing.
In conclusion, our study showed the formation of a 
suitable lamellar bone in the patients that underwent 
maxillary sinus reconstruction after six months of bone 
healing in all groups, thus being indicated to receive 
dental implants.
Acknowledgement
We would like to thank UNIFESO for the financial 
support and scholarship (PICPq 2018/2019) and CNPq 
for the PIBITI scholarship, which allowed the authors 
to develop this study.
Conflict of interest
All authors declare no conflict of interest
Informed consent
An informed consent was obtained from all 
participants included in the study.
Authors’ contributions
Pereira, Rodrigo dos Santos: Conceptualization 
(Equal); Data curation (Equal); Formal analysis 
(Equal); Methodology (Equal); Project administration 
(Equal); Writing of original draft (Equal). Bonardi, 
João Paulo: Conceptualization (Equal); Formal 
analysis (Equal); Investigation (Equal); Writing of 
original draft (Equal). Ouverney, Felippe Ricardo 
Frossard: Data curation (Equal); Formal analysis 
(Equal). Campos, Annelise Backer: Data curation 
PEREIRA RS, BONARDI JP, OUVERNEY FR, CAMPOS AB, GRIZA GL, OKAMOTO R, HOCHULI-VIEIRA E
J Appl Oral Sci. 2021;29:e202005688/9
(Equal); Formal analysis (Equal); Investigation 
(Equal). Griza, Geraldo Luiz: Conceptualization 
(Equal); Investigation (Equal); Project administration 
(Equal); Resources (Equal). Okamoto, Roberta: Data 
curation (Equal); Methodology (Equal); Validation 
(Equal); Visualization (Equal). Hochuli-Vieira, 
Eduardo: Funding acquisition (Equal); Methodology 
(Equal); Supervision (Equal); Article review & editing 
(Equal).
References
1- Misch CE, Resnik RR, Misch-Dietsh F. Maxillary sinus anatomy, 
pathology and graft surgery. In: Mish CE. Contemporary implant 
dentistry. St. Louis: Mosby; 2008. p. 905-74.
2- Palma VC, Magro-Filho O, Oliveria JA, Lundgren S, Salata LA, 
Sennerby L. Bone reformation and implant integration following 
maxillary sinus membrane elevation: an experimental study in 
primates. Clin Implant Dent Relat Res. 2006;8(1):11-24. doi: 
10.2310/j.6480.2005.00026.x
3- Boyne PJ, James RA. Grafting of the maxillary sinus floor with 
autogenous marrow and bone. J Oral Surg. 1980;38(8):613-6.
4- Moy PK, Lundgren S, Holmes RE. Maxillary sinus augmentation: 
histomorphometric analysis of graft materials for maxillary sinus 
floor augmentation. J Oral Maxillofac Surg. 1993;51(8):857-62. doi: 
10.1016/s0278-2391(10)80103-x
5- Rickert D, Slater JJ, Meijer HJ, Vissink A, Raghoebar GM. Maxillary 
sinus lift with solely autogenous bone compared to a combination of 
autogenous bone and growth factors or (solely) bone substitutes: a 
systematic review. Int J Oral Maxillofac Surg. 2012;41(2):160-7. doi: 
10.1016/j.ijom.2011.10.001
6- Aghaloo TL, Moy PK. Which hard tissue augmentation techniques are 
the most successful in furnishing bony support for implant placement? 
Int J Oral Maxillofac Implants. 2007;22 Suppl:49-70.
7- Traini T, Degidi M, Sammons R, Stanley P, Piattelli A. Histologic and 
elemental microanalytical study of anorganic bovine bone substitution 
following sinus floor augmentation in humans. J Periodontol. 
2008;79(7):1232-40. doi: 10.1902/jop.2008.070504
8- Bonardi JP, Pereira RD, Lima FB, Faverani LP, Griza GL, Okamoto R, 
et al. Prospective and randomized evaluation of ChronOS and Bio-Oss in 
human maxillary sinuses: histomorphometric and immunohistochemical 
assignment for RUNX 2, vascular endothelial growth factor, and 
osteocalcin. J Oral Maxillofac Surg. 2018;76(2):325-35. doi: 10.1016/j.
joms.2017.09.020
9- Menezes JD, Pereira RD, Bonardi JP, Griza GL, Okamoto R, 
Hochuli-Vieira E. Bioactive glass added to autogenous bone graft 
in maxillary sinus augmentation: a prospective histomorphometric, 
immunohistochemical, and bone graft resorption assessment. J Appl 
Oral Sci. 2018;26:e20170296.  doi: 10.1590/1678-7757-2017-0296
10- Furusawa T, Mizunuma K. Osteoconductive properties and efficacy 
of resorbable bioactive glass as a bone-grafting material. Implant 
Dent. 1997;6(2):93-101. doi: 10.1097/00008505-199700620-00003
11- Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 
statement: updated guidelines for reporting parallel group randomised 
trials. Int J Surg. 2011;9(8):672-7. doi: 10.1016/j.ijsu.2011.09.004
12- Pereira RS, Gorla LF, Boos FB, Okamoto R, Garcia IR, Hochuli-Vieira 
E. Use of autogenous bone and beta-tricalcium phosphate in maxillary 
sinus lifting: histomorphometric study and immunohi’stochemical 
assessment of RUNX2 and VEGF. Int J Oral Max Surg. 2017;46(4):503-
10.  doi: 10.1016/j.ijom.2017.01.002
13- Pereira RS, Pavelski MD, Griza GL, Boos F, Hochuli-Vieira E. 
Prospective evaluation of morbidity in patients who underwent 
autogenous bone-graft harvesting from the mandibular symphysis and 
retromolar regions. Clin Implant Dent Relat Res. 2019;21(4):753-7. 
doi: 10.1111/cid.12789
14- Merz WA. Die Streckenmessung an gerichteten Strukturen im 
Mikroskop und ihre Anwendung zur Bestimmung von Oberflächen-
Volumen-Relationen im Knochengewebe [Distance measurement of 
directed structures in the microscope and its use in the determination 
of surface and volume relationship in bone tissue]. Mikroskopie. 
1968;22(5):132-42. German.
15- Pereira RS, Boos FB, Gorla LF, Garcia IR, Jr., Okamoto R, Hochuli-
Vieira E. Maxillary sinus elevation surgery with chronos and autogenous 
bone graft: immunohistochemical assessment of RUNX2, VEGF, TRAP, 
and osteocalcin. Int J Periodontics Restorative Dent. 2017;37(6):e321-
7. doi: 10.11607/prd.2606
16- Luvizuto ER, Dias SM, Queiroz TP, Okamoto T, Garcia IR Jr, Okamoto 
R, et al. Osteocalcin immunolabeling during the alveolar healing process 
in ovariectomized rats treated with estrogen or raloxifene. Bone. 
2010;46(4):1021-9. doi: 10.1016/j.bone.2009.12.016
17- Lindhe J, Cecchinato D, Donati M, Tomasi C, Liljenberg B. Ridge 
preservation with the use of deproteinized bovine bone mineral. Clin 
Oral Implants Res. 2014;25(7):786-90. doi: 10.1111/clr.12170
18- Hallman M, Lundgren S, Sennerby L. Histologic analysis of clinical 
biopsies taken 6 months and 3 years after maxillary sinus floor 
augmentation with 80% bovine hydroxyapatite and 20% autogenous 
bone mixed with fibrin glue. Clin Implant Dent Relat Res. 2001;3(2):87-
96. doi: 10.1111/j.1708-8208.2001.tb00236.x
19- Lindgren C, Mordenfeld A, Johansson CB, Hallman M. A 3-year 
clinical follow-up of implants placed in two different biomaterials 
used for sinus augmentation. Int J Oral Maxillofac Implants. 
2012;27(5):1151-62.
20- Pereira RD, Menezes JD, Bonardi JP, Griza GL, Okamoto R, Hochuli-
Vieira E. Histomorphometric and immunohistochemical assessment of 
RUNX2 and VEGF of Biogran (TM) and autogenous bone graft in human 
maxillary sinus bone augmentation: a prospective and randomized 
study. Clin Implant Dent Relat Res. 2017;19(5):867-75. doi: 10.1111/
cid.12507
21- Rodriguez y Baena R, Pastorino R, Gherlone EF, Perillo L, Lupi 
SM, Lucchese A. Histomorphometric evaluation of two different bone 
substitutes in sinus augmentation procedures: a randomized controlled 
trial in humans. Int J Oral Maxillofac Implants. 2017;32(1):188-
94.  doi: 10.11607/jomi.4752
22- Lee JS, Shin HK, Yun JH, Cho KS. Randomized clinical trial of 
maxillary sinus grafting using deproteinized porcine and bovine 
bone mineral. Clin Implant Dent Relat Res. 2017;19(1):140-50. doi: 
10.1111/cid.12430
23- Nizam N, Eren G, Akcali A, Donos N. Maxillary sinus augmentation 
with leukocyte and platelet-rich fibrin and deproteinized bovine bone 
mineral: a split-mouth histological and histomorphometric study. Clin 
Oral Implants Res. 2018;29(1):67-75. doi: 10.1111/clr.13044
24- Tadjoedin ES, Lange GL, Lyaruu DM, Kuiper L, Burger EH. High 
concentrations of bioactive glass material (BioGran) vs. autogenous 
bone for sinus floor elevation - Histomorphometrical observations on 
three split mouth clinical cases. Clin Oral Implants Res. 2002;13(4):428-
36. doi: 10.1034/j.1600-0501.2002.130412.x
25- Hirsch JM, Ericsson I. Maxillary sinus augmentation using 
mandibular bone grafts and simultaneous installation of implants: 
a surgical technique. Clin Oral Implants Res. 1991;2(2):91-6. doi: 
10.1034/j.1600-0501.1991.020207.x
26- Lundgren S, Moy P, Johansson C, Nilsson H. Augmentation of 
the maxillary sinus floor with particulated mandible: a histologic 
and histomorphometric study. Int J Oral Maxillofac Implants. 
1996;11(6):760-6.
The new bone formation in human maxillary sinuses using two bone substitutes with different resorption types associated or not with autogenous bone graft: a comparative 
histomorphometric, immunohistochemical and randomized clinical study
J Appl Oral Sci. 2021;29:e202005689/9
27- Wood RM, Moore DL. Grafting of the maxillary sinus with intraorally 
harvested autogenous bone prior to implant placement. Int J Oral 
Maxillofac Implants. 1988;3(3):209-14.
28- Yildirim M, Spiekermann H, Handt S, Edelhoff D. Maxillary sinus 
augmentation with the xenograft Bio-Oss and autogenous intraoral 
bone for qualitative improvement of the implant site: a histologic 
and histomorphometric clinical study in humans. Int J Oral Maxilloafc 
Implants. 2001;16(1):23-33.
29- Jensen T, Schou S, Gundersen HJG, Forman JL, Terheyden H, 
Holmstrup P. Bone-to-implant contact after maxillary sinus floor 
augmentation with Bio-Oss and autogenous bone in different ratios 
in mini pigs. Clin Oral Implants Res. 2013;24(6):635-44. doi: 
10.1111/j.1600-0501.2012.02438.x
30 - Jensen T, Schou S, Stavropoulos A, Terheyden H, Holmstrup P. 
Maxillary sinus floor augmentation with Bio-Oss or Bio-Oss mixed with 
autogenous bone as graft: a systematic review. Clin Oral Implants 
Res. 2012;23(3):263-73. doi: 10.1111/j.1600-0501.2011.02168.x
31- Cordioli G, Mazzocco C, Schepers E, Brugnolo E, Majzoub Z. 
Maxillary sinus floor augmentation using bioactive glass granules and 
autogenous bone with simultaneous implant placement: clinical and 
histological findings. Clin Oral Implants Res. 2001;12(3):270-8. doi: 
10.1034/j.1600-0501.2001.012003270.x
32- Turunen T, Peltola J, Yli-Urpo A, Happonen RP. Bioactive glass 
granules as a bone adjunctive material in maxillary sinus floor 
augmentation. Clin Oral Implants Res. 2004;15(2):135-41. doi: 
10.111/j.1600-0501.2004.00989.x
33- Lorenz J, Al-Maawi S, Sader R, Ghanaati S. Individualized titanium 
mesh cambined with platelet-rich fibrin and deproteinized bovine 
bone: a new approach for challenging augmentation. J Oral Implantol. 
2018;44(5):345-51. doi: 10.1563/aaid-joi-D-18-00049
PEREIRA RS, BONARDI JP, OUVERNEY FR, CAMPOS AB, GRIZA GL, OKAMOTO R, HOCHULI-VIEIRA E
